Recently, prostate-specific membrane antigen (PSMA) inhibitors conjugated with the radionuclides 68Ga and 18F-fluoride have been well-explored and successfully translated for the clinical diagnosis of PCa [7,8]. Here, FOLH1 is linked to posterior cortical atrophy.